AI-driven drug discovery, using LLMs and diffusion models, has improved drug design and reduced timelines. Although promising, limited interpretability and data silos could limit its ability to ...
The seven companies listed here cover the realistic range of what a buyer will encounter in 2026: embedded ML teams that own ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results